BridgeMD
New treatment option for Lips Enhancement
Official title Evaluation of Facial HA Dermal Fillers in Real-Life Conditions
ClinicalTrials.gov ID: NCT07255261
What this study is testing
- What it's testing
- The goal of this post-market interventional study is to confirm, under real-life conditions, the safety and performance of hyaluronic acid-based dermal fillers intended to modify skin anatomy and facial appearance. Subjects aged 18 years or older seeking aesthetic treatment of the lips, perioral lines, nasolabial folds, cheeks, and/or infraorbital hollows may be included.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Subject seeking an aesthetic correction of the infraorbital hollows with FASY P and/ or an aesthetic correction of the lips with ESTYME® LIPS, and/...
- Subject who agreed to participate and have signed an informed consent.
- Age: over 18 years old.
- Subject being affiliated to a health social security system.
You likely can't join if
- Minors
- people with a known allergy to hyaluronic acid, lidocaine or amide local anesthetics.
- people with porphyria.
- people with an autoimmune disorder, or using an immunosuppressant medication.
- Pregnant or breastfeeding women.
- people with inflammation, infection or cutaneous disorders, at the treatment site or nearby.
See the full eligibility criteria
- Subject seeking an aesthetic correction of the infraorbital hollows with FASY P and/ or an aesthetic correction of the lips with ESTYME® LIPS, and/ or an aesthetic correction of the perioral lines with ESTYME® SMOOTH...
- Subject who agreed to participate and have signed an informed consent.
- Age: over 18 years old.
- Subject being affiliated to a health social security system.
- Minors
- people with a known allergy to hyaluronic acid, lidocaine or amide local anesthetics.
- people with porphyria.
- people with an autoimmune disorder, or using an immunosuppressant medication.
- Pregnant or breastfeeding women.
- people with inflammation, infection or cutaneous disorders, at the treatment site or nearby.
- people with bleeding disorders or in people receiving thrombolytic or anticoagulant treatment.
- Areas other than those recommended by the IFU.
- Subject deprived of liberty by judicial or administrative decision.
- Adults under a legal protection measure (guardianship/curatorship).
- Subject under legal protection order.
The study team makes the final eligibility decision.
Where it's taking place
- Arras, France
- Lyon, France
- Palaiseau, France
- Paris, France
- Saint-Maur-des-Fossés, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Arras, France; Lyon, France; Palaiseau, France; Paris, France; Saint-Maur-des-Fossés, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.